ABSTRACT Here, we report 12 draft genome sequences of mutant Mycolicibacterium smegmatis strains resistant to imidazo [1,2-b][1,2,4,5]tetrazines, which are antituberculosis drug candidates. We have identified 7 different mutations in the MSMEG_1380 gene, which encodes the AcrR/TetR_N transcriptional repressor, which may activate efflux-mediated resistance. W e have previously described a number of substituted imidazo[1,2-b][1,2,4,5]tetrazines that showed promising MICs against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains. We used Mycolicibacterium smegmatis (formerly Mycobacterium smegmatis) as the model organism to study drug resistance mechanisms of mycobacteria to these compounds. We were able to obtain M. smegmatis mc2 155 spontaneous mutants that were resistant to 4 different imidazo [1,2-b] [1, 2, 4, 5] tetrazines at 3.5 to 4ϫ MIC (1; D. A. Maslov, A.
AcrR/TetR_N transcriptional regulator, which is involved in the regulation of gene expression of MmpS5/MmpL5 transmembrane transporters. It has been previously reported that overexpression of the mmpS5-mmpL5 operon modulates resistance to the derivatives of thiacetazone in Mycobacterium abscessus (7) and cross-resistance to bedaquiline and clofazimine in M. tuberculosis (8) .
Data availability. The whole-genome shotgun (WGS) assemblies have been deposited in NCBI GenBank; the versions described in this paper are the first versions. The read archives have been deposited in NCBI SRA. The WGS (GenBank) and SRA accession numbers are listed in Table 1 
